Considerations in the use of lipid-based drug products

Research output: Contribution to journalReview article

Abstract

The availability and use of intravenous lipid-based drug products is increasing. These products may have increased efficacy, decreased adverse effects, or both when compared with conventional formulations of the same drug. Lipid-based drug products have nutrition support implications when a substantial caloric dose is received during administration of the drug. They also have unique toxicities and much greater costs than do traditional therapies. The rationale for the use of lipid-based drug products is presented, along with an overview of the proper use of current commercially available lipid-based amphotericin B, propofol, daunorubicin, and doxorubicin products.

Original languageEnglish (US)
Pages (from-to)45-49
Number of pages5
JournalJournal of Intravenous Nursing
Volume21
Issue number1
StatePublished - Jan 1 1998

Fingerprint

Lipids
Pharmaceutical Preparations
Drug Compounding
Daunorubicin
Amphotericin B
Propofol
Doxorubicin
Costs and Cost Analysis
Therapeutics

All Science Journal Classification (ASJC) codes

  • Nursing(all)
  • Critical Care and Intensive Care Medicine

Cite this

Considerations in the use of lipid-based drug products. / Wood, G Christopher; Brown, Rex O.; Dickerson, Roland.

In: Journal of Intravenous Nursing, Vol. 21, No. 1, 01.01.1998, p. 45-49.

Research output: Contribution to journalReview article

@article{75e3d029dd914d2aaeee54fc7f3ec593,
title = "Considerations in the use of lipid-based drug products",
abstract = "The availability and use of intravenous lipid-based drug products is increasing. These products may have increased efficacy, decreased adverse effects, or both when compared with conventional formulations of the same drug. Lipid-based drug products have nutrition support implications when a substantial caloric dose is received during administration of the drug. They also have unique toxicities and much greater costs than do traditional therapies. The rationale for the use of lipid-based drug products is presented, along with an overview of the proper use of current commercially available lipid-based amphotericin B, propofol, daunorubicin, and doxorubicin products.",
author = "Wood, {G Christopher} and Brown, {Rex O.} and Roland Dickerson",
year = "1998",
month = "1",
day = "1",
language = "English (US)",
volume = "21",
pages = "45--49",
journal = "Journal of Infusion Nursing",
issn = "1533-1458",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Considerations in the use of lipid-based drug products

AU - Wood, G Christopher

AU - Brown, Rex O.

AU - Dickerson, Roland

PY - 1998/1/1

Y1 - 1998/1/1

N2 - The availability and use of intravenous lipid-based drug products is increasing. These products may have increased efficacy, decreased adverse effects, or both when compared with conventional formulations of the same drug. Lipid-based drug products have nutrition support implications when a substantial caloric dose is received during administration of the drug. They also have unique toxicities and much greater costs than do traditional therapies. The rationale for the use of lipid-based drug products is presented, along with an overview of the proper use of current commercially available lipid-based amphotericin B, propofol, daunorubicin, and doxorubicin products.

AB - The availability and use of intravenous lipid-based drug products is increasing. These products may have increased efficacy, decreased adverse effects, or both when compared with conventional formulations of the same drug. Lipid-based drug products have nutrition support implications when a substantial caloric dose is received during administration of the drug. They also have unique toxicities and much greater costs than do traditional therapies. The rationale for the use of lipid-based drug products is presented, along with an overview of the proper use of current commercially available lipid-based amphotericin B, propofol, daunorubicin, and doxorubicin products.

UR - http://www.scopus.com/inward/record.url?scp=0344541819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344541819&partnerID=8YFLogxK

M3 - Review article

VL - 21

SP - 45

EP - 49

JO - Journal of Infusion Nursing

JF - Journal of Infusion Nursing

SN - 1533-1458

IS - 1

ER -